baber/WOPTO huggingface dataset:
Patent AU-689370-B2 (AU)
Title: Earmuff
Inventor: NILSSON LARS BERTIL
IPC: H04R1/10
Filed: 1996-01-30
Granted: 1998-03-26
Abstract: PCT No. PCT/SE96/00105 Sec. 371 Date Jul. 10, 1997 Sec. 102(e) Date Jul. 10, 1997 PCT Filed Jan. 30, 1996 PCT Pub. No. WO96/23462 PCT Pub. Date Aug. 8, 1996Earmuff and method for changing the noise attenuation characteristic of an earmuff. The change is obtained by providing foam-filled sealing ring of the earmuff in the annular covering thereof with a large number of ventilation apertures which are uniformly distributed along the sealing ring, thereby affecting the air spring action of the sealing ring. The ventilation apertures communicate with the environment without communicating with interior of the earmuff. By reducing the air spring action to a considerable extent, the low frequency attenuation is improved. The communication with the environment provides "acoustic ducts", particular by using special ventilation ducts which can be dimensioned to give a selective noise transmission, dependent on the duct resonance, into the sealing ring, thereby selectively affecting the noise attenuation characteristic.
Patent AU-711121-B2 (AU)
Title: Viral preparations, vectors, immunogens, and vaccines
Inventor: INGLIS STEPHEN CHARLES
IPC: A61K39/00
Filed: 1996-02-21
Granted: 1999-10-07
Abstract: A genetically disabled mutant virus has a genome which is defective in respect of a selected gene that is essential for the production of infectious new virus particles, and which carries heterologous genetic material encoding an immunomodulatory protein such as GM-CSF, Il-2 or others, such that the mutant virus can infect normal host cells and cause expression of immunomodulatory protein, but the mutant virus cannot cause production of infectious new virus particles except when the virus infects recombinant complementing host cells expressing a gene that provides the function of the essential viral gene; the site of insertion of the heterologous genetic material encoding the immunomodulatory protein preferably being at the site of the defect in the selected viral gene. Uses include prophylactic and therapeutic use in generating an immune response in a subject treated therewith; use in the preparation of an immunogen such as a vaccine for use in tumour therapy; use in the in-vitro expansion of (e.g. virus-specific) cytotoxic T cells; and therapeutic or prophylactic use in corrective gene therapy.
Patent AU-748591-B2 (AU)
Title: Pressure-sensitive adhesive composition and moisture-permeable pressure-sensitive adhesive tape, pressure-sensitive adhesive drug composition, and pressure-sensitive adhesive tape preparation each containing the composition
Inventor: KITAZONO EIICHI
IPC: C09J7/02
Filed: 1999-07-27
Granted: 2002-06-06
Abstract: The adhesive agent composition of the present invention comprises from 50 to 90% by weight of an acrylic adhesive agent, 2.5 to 50% by weight of a polyhydric alcohol-containing liquid component, and 0.01 to 10% by weight of a salt of a mono- to tri-valence metal of an aliphatic acid that contains a hydrocarbon group of 8 to 18 carbon atoms. The adhesive agent composition shows good adhesion, cohesive force and permeability, and an adhesive drug composition having the above properties can be prepared by adding a drug (medicine, etc.) to the adhesive composition. An adhesive tape excellent in permeability or an adhesive tape preparation excellent in permeability and cutaneous absorption of the drug can be produced by coating a substrate with the adhesive agent composition or adhesive drug composition.
Patent AU-700077-B2 (AU)
Title: Substituted benzothienylpiperazines their use as medicaments, and processes for their preparation
Inventor: HRIB NICHOLAS J
IPC: C07D409/04
Filed: 1996-03-14
Granted: 1998-12-17
Abstract: This invention relates to compounds of the formula I <CHEM>  wherein   X   is hydrogen, halogen, hydroxy, (C1-C6)alkoxy, amino or trifluoromethyl;  and   Y   is -CN or -NR<1>R<2>;  where   l   is an integer of 1 or 2; m   is an integer of 0, 1 or 2; n   is an integer of 2, 3 or 4, except when Y is CN, in which case n can also be 1; R<1>   is hydrogen, (C1-C6)alkyl or (C1-C6)alkylcarbonyl; R<2>   is hydrogen, (C1-C10)alkylcarbonyl, (C3-C12)cycloalkylcarbonyl, hydroxy-(C1-C6)alkylcarbonyl, phenylcarbonyl, thienylcarbonyl or  benzothienylcarbonyl; or   R<1> and R<2>   together with nitrogen atom to which they are attached form the ring <CHEM>    where   A   is C = O or CH2; and B   is C = O, CHOH, CH2 or CH2CH2; and Z   is hydrogen, halogen, hydroxy, (C1-C6)alkoxy, amino or trifluoro; and pharmaceutically acceptable acid addition salts thereof, pharmaceutical compositions thereof and their use for the treatment of psychoses.
Patent AU-631181-B2 (AU)
Title: Positive-displacement pump
IPC: F04B47/02
Filed: 1990-01-24
Granted: 1992-11-19
Abstract: A submersible positive-displacement pump comprises a pump housing (10A/10B) having an inlet (11) at its lower portion and an outlet (17-19) at its upper portion, a variable-volume pump chamber (21) which is provided at the lower portion (10A) of the pump housing and communicates with the inlet through an annular passage (29) having a one-way inlet valve (23) and communicating with the outlet through an opening (20) controlled by a one-way outlet valve (30). A displacement member (27) below the pump chamber (21) is connected with a lifting member (28) which extends upwardly from the pump housing and is connected to a driving device. By means of the lifting member the displacement member can be reciprocated vertically for reducing and increasing the volume of the pump chamber. The pump chamber (21) is defined partly by a circumferentially extending pump housing wall (22) and partly by a sealing coolar (23) which bridges the annular passage (29) and one circumferential end of which is movable in the pump chamber towards and away from the pump housing wall (22) in order to open and close the passage under the influence of a pressure differential between the pump chamber (21) and the inlet (11).
Patent AU-622013-B2 (AU)
Title: Process for reducing propenyl ether concentration in hydroxy-functional polyether compounds
Inventor: CHAVEZ JOHNNY JR
IPC: B01J31/08
Filed: 1990-03-06
Granted: 1992-03-26
Abstract: The concentration of propenyl ethers in a hydroxy-functional polyether having oxypropylene units is reduced by a process including the step of contacting the polyether with an acid ion exchange resin for a time and at a temperature sufficient for the conversion of at least some of the propenyl ethers to propionaldehyde and in the presence of sufficient water for the conversion. Optionally, the polyether is treated with an epoxy compound in an amount sufficient to reduce the acidity of the polyol.
Patent AU-732112-B2 (AU)
Title: Formulation in the form of a matrix material-excipient compound, matrix material-active substance compound and/or matrix material-excipient-active substance compound, and processes for the preparation thereof and the use thereof for the preparation of tablets and/or other larger matrix units
Inventor: MULLER RAINER H
IPC: A61K9/16
Filed: 1997-12-10
Granted: 2001-04-12
Abstract: The invention relates to a preparation in the form of a compound containing a matrix material, with an auxiliary substance phase with at least one auxiliary substance and/or an active substance phase with at least one active substance, and a matrix material phase with at least one polymer and/or lipid. The invention is characterized in that the matrix material phase of the preparation is incoherent, and the auxiliary and/or active substance phase of the preparation is coherent. In addition, a method for the production of this preparation is described. This preparation is suited for the production of larger matrix units with controlled release characteristics in accordance with known methods, and in particular for the production of tablets by means of direct compressing.
Patent AU-643949-B2 (AU)
Title: Pressure reducing and conditioning valves
Inventor: KUEFFER MAX
IPC: F16K11/20
Filed: 1990-05-21
Granted: 1993-12-02
Abstract: Pressure reduction and conditioning valve for simultaneously reducing the pressure and temperature of steam. The invention comprises a valve body divided into first and second chambers, the first chamber having an inlet port for the introduction of superheated steam under high pressure into said conditioning valve and the second chamber having an outlet port for expelling desuperheated and depressurized steam out of said conditioning valve; an annular seat affixed to the interior of said valve between said first and second chambers; a hollow cylindrical cage slidably coupled with said seat, said cage permitting the flow of steam between said first and second chambers when said cage is in a first position and permitting a controlled leakage of steam when said cage is in a second position; and water stem means coupled to said cage for adjusting said cage between said first and second positions, said stem means having an outlet for injecting desuperheating water into said second chamber to be mixed with said steam.
Patent AU-685075-B2 (AU)
Title: Pharmaceutical composition for treating nicotine dependence
Inventor: MOORMANN JOACHIM ARNOLD
IPC: A61K31/55
Filed: 1994-01-10
Granted: 1998-01-15
Abstract: PCT No. PCT/EP94/00055 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed Jan. 10, 1994 PCT Pub. No. WO94/16708 PCT Pub. Date Aug. 4, 1994The present invention relates to the use of galanthamine and the pharmaceutically acceptable acid addition salts thereof for the treatment of nicotine dependence. The active substances are released from pharmaceutical formulations, e.g., orally, transdermally, or otherwise parenterally in a continuous and controlled manner.
Patent AU-733433-B2 (AU)
Title: A binaural digital hearing aid system
Inventor: WESTERMANN SOREN ERIK
IPC: H04R25/00
Filed: 1998-02-18
Granted: 2001-05-17
Abstract: In a binaural hearing aid with signal processors in each unit, each signal processor includes a first processor part for hearing compensation processing of signals representing the sound received at that unit, and a second processor part for hearing compensation processing of signals received from the other unit via a communications link.
Patent AU-625885-B2 (AU)
Title: New n-(23-vinblastinoyl) and n-(5'-noranhydro-23- vinblastinoyl) derivatives of 1-aminomethylphosphonic acid, process for preparing these and pharmaceutical compositions containing them
Inventor: LAVIELLE GILBERT
IPC: C07F9/32
Filed: 1990-08-03
Granted: 1992-07-16
Abstract: Compounds of general formula I: 
<IMAGE>
 in which: 
 
  - R1 denotes a hydrogen atom, a linear or branched alkyl radical containing from 1 to 6 carbon atoms, a linear or branched alkenyl radical containing from 2 to 6 carbon atoms, an arylalkyl radical of 7 to 10 carbon atoms capable of carrying as substituent on the aromatic ring a halogen atom, a hydroxyl radical or an alkyl or alkoxy radical, each containing from 1 to 5 carbon atoms, a 2-indolylmethyl radical, a 4-imidazolylmethyl radical, or an alkoxycarbonylmethyl radical containing from 3 to 11 carbon atoms, 
  - each of R2 and R3, which are identical or different, denotes a linear or branched alkyl radical containing from 1 to 6 carbon atoms, 
  - n is equal to 1 or 2, 
  - R4 denotes a hydrogen atom, a formyl radical or a methyl radical, provided, however, that R4 is never a methyl radical when n is equal to 2, and 
  - either R5 and R6 together form a double bond or R5 denotes a hydrogen atom and R6 a hydroxyl radical, 
 in the form of mixture of pure diastereoisomers or isomers, their Nb'-oxides and their salts of addition to a pharmaceutically acceptable inorganic or organic acid. 
<??>These compounds are antitumour agents.
Patent AU-718160-B2 (AU)
Title: Soft gelatin capsules containing particulate material
Inventor: TANNER KEITH E
IPC: A61K9/64
Filed: 1996-06-06
Granted: 2000-04-06
Abstract: Disclosed are suspensions suitable for encapsulation in gelatin capsules, comprising a solid phase consisting of solid particles having a mean diameter of at least about 149 mum, and a liquid phase capable of suspending the solid phase, the suspension having a predetermined rheology at a temperature suitable for encapsulation into gelatin capsules.
Patent AU-647040-B2 (AU)
Title: A recombinant birth control vaccine
Inventor: TALWAR GURSARAN PRASAD
IPC: C12R1/92
Filed: 1990-08-31
Granted: 1994-03-17
Abstract: A recombinant birth control vaccine comprising a beta subunit of chorionic gonadotropin, a recombinant luteinizing hormone or a mixture thereof has been developed. This recombinant birth control vaccine may also act as a vaccine against a protein or peptide unassociated with the mammalian reproductive system, such as a protein or peptide associated with a disease organism such as hepatitis B.
Patent AU-581535-B2 (AU)
Title: Suture anchor assembly
Inventor: GOBLE E MARLOWE
IPC: A61B17/16
Filed: 1986-08-26
Granted: 1989-02-23
Abstract: A cylindrical suture anchor having a drill formed on one end (13) thereof and flights of threads (14) formed on the other whereto at least one section of suture is permanently secured, the anchor to be turned through a driver (12) maintained and turned by a separate drilling device operated by an orthopedic surgeon. In practice, the surgeon positions the suture anchor drill end on a point on a bone mass in a human body and, by turning the driver, turns the suture anchor to drill into the bone mass, until a first thread flight engages the drilled hole wall and is turned therein, tapping that hole, to receive each following thread flight, until the anchor is seated therein, during which seating the driver is telescoped out of a splined coupling (18, 19) to the anchor and a suture (24) secured in a longtudinal opening (27) in the anchor that is folded into the driver is pulled from that driver for use by the orthopedic surgeon in securing a ligament to that point on the bone mass.
Patent AU-629697-B2 (AU)
Title: Plasma arc torch having extended nozzle of substantially hourglass
Inventor: CARKHUFF DONALD WESLEY
IPC: B23K10/00
Filed: 1990-10-04
Granted: 1992-10-08
Abstract: A nozzle 40 for use with a plasma arc torch 10 having a first gas flow within the nozzle 40 for engaging an electrode 31 and generating a plasma and a second gas flow in surrounding engagement to the outer surface of the nozzle 40 is disclosed. The nozzle 40 includes an outer surface 53 of substantially hourglass configuration in longitudinal cross-section so that the second gas remains in close contact with the outer hourglass surface 53 of the nozzle 40 to provide efficient heat transfer from the nozzle 40 to the surrounding second gas flow.
Patent AU-648043-B2 (AU)
Title: Process for the preparation of aqueous dispersions
Inventor: ROSSLING GEORG
IPC: A61K9/127
Filed: 1990-10-12
Granted: 1994-04-14
Abstract: A process is described for the production of aqueous dispersions involving removal of liquid(s) from an optionally multiphase liquid mixture by means of membrane distillation, e.g., transmembrane distillation or pervaporation.
Patent AU-630765-B2 (AU)
Title: Anti-jamming device for security screens
Inventor: CARDINAL MICHAEL JOHN
IPC: E05G5/00
Filed: 1990-11-14
Granted: 1992-11-05
Abstract: An anti-jamming device for a security screen arrangement, in which a security screen is able to be rapidly fired from a rest position to an upper position at which passage of a person from one side of the screen to another is not possible, includes sensors (24, 26) for detecting whether the screen is at the rest position or the upper position. The device also includes a valve for lowering a screen when it does not reach the upper position, due to the screen having been jammed, and for reactivating the firing of the screen. The screen may be repeatedly fired until the obstruction is cleared.
Patent AU-720395-B2 (AU)
Title: Micro-domain graphitic materials and method for producing the same
Inventor: LYNUM STEINAR
IPC: C01B31/04
Filed: 1998-03-20
Granted: 2000-06-01
Abstract: This invention relates to a method for producing micro-domain graphitic materials by use of a plasma process, and to novel micro-conical graphitic materials. By micro-domain graphitic materials we mean fullerenes, carbon nanotubes, open conical carbon structures (also named micro-cones), preferably flat graphitic sheets, or a mixture of two or all of these. The novel carbon material is open carbon micro-cones with total disclination degrees 60 DEG  and/or 120 DEG , corresponding to cone angles of respectively 112.9 DEG  and/or 83.6 DEG .
Patent AU-591225-B2 (AU)
Title: Paramagnetic chelates
Inventor: FELDER ERNST PROF DR
IPC: C07C229/46
Filed: 1987-01-13
Granted: 1989-11-30
Abstract: Compounds suitable for NMR imaging having the formula:whereina is 2 or 3;b is an integer from 0 to 4;Me<sup>(a+)</sup> is Fe<sup>(2+)</sup>, Fe<sup>(3+)</sup>, Gd<sup>(3+)</sup>, or Mn<sup>(2+)</sup>;E<sup>(b+)</sup> is an ion of an alkali metal, alkaline earth metal, alkyl ammonium, alkanol ammonium, polyhydroxyalkyl ammonium, or basic protonated amino acid, said ions representing a total charge of b; m is an integer from I to 5;R is H, alkyl with from I to 8 carbon atoms, alkyl with from I to 8 carbon atoms wherein from I to 5 carbons are substituted with OH; aralkyl with I to 4 aliphatic carbon atoms; phenyl or phenyl substituted by halogen, hydroxyl, carboxyl, carboxamide, ester, SO<sub>3</sub>H, sulfonamide, lower alkyl, lower hydroxy alkyl, amino, acylamino; (poly)oxa-alkyl with I to 50 oxygen atoms and from 3 to i50 carbon atoms, wherein I to 5 hydrogen atoms may be substituted by OH;R, is -CH<sub>2</sub>COOZ, -CH(CH<sub>3</sub>)COOZ, CH<sub>2</sub>CH<sub>2</sub>-N(CH<sub>2</sub>COOZ)<sub>2</sub>, a hydroxy arylalkyl, hydroxy pyridylalkyl, hydroxy aryl(carboxy)alkyl or hydroxy pyridyl-(carboxy)-alkyl radical, where the aryl or pyridyl radical may be substituted by hydroxyl, hydroxy alkyl, alkyl, halogen, carboxyl or SO<sub>3</sub>H;R<sub>2</sub> is the same as R, or iswhereinR<sub>3</sub> is -CH<sub>2</sub>COOZ, -CH(CH<sub>3</sub>)COOZ or a monovalent radical having the structure R-O-(CH<sub>2</sub>)<sub>m</sub>- CH-COOZ;X is a direct chemical bond, -O-, -S-, -NH-, -N -CH<sub>2</sub>COOZ or - N -CH(CH<sub>3</sub>)COOZ;n is the integer 2 or 3, with the proviso that when X represents a direct bond, n is I, 2 or 3;Z. is hydrogen or a unit of negative charge, and -(CH2)<sub>m</sub>-may also be -CH<sub>2</sub>-C(CH<sub>3</sub>)<sub>2</sub>-.The compounds are relatively simple, well tolerated, partially endowed with organ specificity and are suitable for application in nuclear spin tomography. The compounds may be prepared by reacting inventive free polyamino-polycarboxylic acids having the formulawhere R, R, R<sub>2</sub> and m have the same meaning as in formula I, or alkali metal, alkaline earth metal and/or amino salts of said acids, with salts, oxides, or hydroxides of iron<sup>(2+)</sup>, iron<sup>(3+)</sup>, gadolinium<sup>(3+)</sup>, or manganese <sup>(2+)</sup>, or with the basic salts of these metal ions. Imaging compositions and methods of use are also disclosed.
Patent AU-592612-B2 (AU)
Title: Tamper evident closure and method of manufacture
Inventor: THOMPSON MORTIMER STAFFORD
IPC: B29C53/12
Filed: 1986-12-05
Granted: 1990-01-18
Abstract: A tamper evident cap (10) for a container having a plastic curled ring (16) at its lower end of reduced internal dimensions for engaging the underside of interfering means (40) on the container (36) and which has induced stresses therein that enhance and reinforce its engaging function. In addition, lines of weakness (25) are included as a peripheral line of weakness above the curled ring or vertical lines of weakness (90) in the curled ring (16) or both. In capping, the curled ring (16) is sufficiently resilient to pass about and below the container interfering means (40) and into interfering engagement therewith without rupturing the described lines of weaknesses (25,90). In the initial uncapping, either the peripheral line of weakness (25) will rupture leaving the ring (16) on the container (36) or the vertical lines of weakness (90) will rupture and separate the ring (16) into segments while allowing the entire cap to be removed. In either embodiment clear evidence of tampering or opening is provided. In forming the cap, the cap preferably is formed by conventional molding techniques such as injection molding with a plastic preform for forming the curled ring. The curled ring is subsequently formed by tools of the invention that curl the preform into desired cross sectional shapes such as an O, U, J or coil. <IMAGE>
Patent AU-730080-B2 (AU)
Title: Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
Inventor: PERRON HERVE
IPC: C12Q1/6883
Filed: 1996-08-02
Granted: 2001-02-22
Abstract: Isolated and purified viral material (A) includes, in the genome, (a) one of 10 sequences given in the specification (from about 400 bp to 2.5 kb); (b) their complements or (c) sequences equiv. to (a) and (b) and having at least 50, pref. 70, % homology with (a) and (b) over a stretch of 100 contiguous nucleotides. New nucleotide fragments (B) comprise: (i) any complete or partial genomic sequence of the pol gene of virus MSRV-1 (multiple sclerosis related virus), excluding a specified 1158 bp sequence (S1); (ii) all partial or complete genomic env or gag gene sequence of MSRV-1; (iii) any sequence that overlaps the pol and env or pol and gag genes; (iv) any partial or complete sequence from those 10 sequences from (A) given in the specification, i.e. from the clones FBd3, t pol, JLBc1, JLBc2, GM3, FBd13, LB19, LTRGAG12, FP6 and G+E+A, but excluding sequences identical to, or contg., S1; (v) sequences complementary to the above genomic sequences; (vi) any equiv. sequence; (B) does not comprise or include the ERV (endogenous retroviral)-9 sequence.
Patent AU-719151-B2 (AU)
Title: Apparatus and method for cutting and treating vegetation
Inventor: BURCH THOMAS B
IPC: A01D43/14
Filed: 1996-08-16
Granted: 2000-05-04
Abstract: An apparatus and a method for cutting vegetation and simultaneously treating the remaining stems of the cut vegetation with a treatment fluid. The apparatus includes a mower (42), a cutting blade drive means (60) rotatably mounted on the mower (42), a blade carrier (92) secured to the rotatable drive means (60), and at least one cutting blade assembly (100) rotatably mounted on the blade carrier (92). The apparatus further includes fluid container means (130) for containing the treatment fluid in a plurality of interconnected, stackable and removable fluid-containing cells (32), pumping means (150) for pumping the treatment fluid to the at least one cutting blade assembly (100), flow control means (160) for metering the amount of treatment fluid that is pumped to the at least one cutting blade assembly (100), and fluid conduit means (190) for delivering the treatment fluid from the fluid container means (130) to the cutting and treating means (90). The method includes the steps of cutting vegetation with at least one cutting blade, and delivering a treatment fluid to the underside of the at least one cutting blade in a continuous stream so that the treatment fluid is continuously available to the remaining stems of the cut vegetation.
Patent AU-598519-B2 (AU)
Title: Device for the administration of medicament suspensions
Inventor: GRAU ULRICH
IPC: A61J1/06
Filed: 1987-02-25
Granted: 1990-06-28
Abstract: A medicament container, such as an injection ampule, for multiple administration of medicament suspensions the containers is filled with medicament so as to be free of gas bubbles, and includes at least one inert mixing element of suitable size whose density is different from that of the suspension. The mixing element acts to homogenize the medicament suspension as the container is shaken.